Dow Down 1.17% Nasdaq Down 1.19%

Oragenics Inc. (OGEN)

-NYSE MKT
0.92 Apr 28, 4:00PM EDT
Prev Close:0.92
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:7.00
Beta:0.288137
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.66 - 3.87
Volume:0
Avg Vol (3m):26,244
Market Cap:36.65M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oragenics, Inc. develops, markets, and sells oral probiotics products and antibiotics for humans and companion pets. The company develops and markets probiotic products comprising ProBiora3, ProBiora3, a blend of oral care probiotics that promote ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback